Recent Quotes (30 days)

You have no recent quotes
chg | %

Market summary

Feb 12 - Markets closed

World markets

Shanghai 2,763.49 -17.53 (-0.63%)
Nikkei 225 14,952.61 -760.78 (-4.84%)
Hang Seng Index 18,319.58 -226.22 (-1.22%)
TSEC 8,063.00 -68.24 (-0.84%)
FTSE 100 5,707.60 +170.63 (3.08%)
EURO STOXX 50 2,756.16 +75.81 (2.83%)
CAC 40 3,995.06 +98.35 (2.52%)
S&P TSX 12,381.24 +293.80 (2.43%)
S&P/ASX 200 4,765.30 -55.80 (-1.16%)
BSE Sensex 22,986.12 +34.29 (0.15%)
TA25 1,397.61 +14.27 (1.03%)
SMI 7,656.60 +159.98 (2.13%)
ATX 2,033.48 +76.43 (3.91%)
IBOVESPA 39,808.05 +489.74 (1.25%)
SET 1,276.49 -4.25 (-0.33%)
BIST100 70,937.40 -4.25 (-0.01%)
IBEX 7,920.80 +174.50 (2.25%)
WIG 43,849.40 +107.44 (0.25%)
TASI 5,557.92 -102.94 (-1.82%)
MERVAL 12,682.02 +225.42 (1.81%)
IPC 42,416.44 +57.18 (0.13%)
IDX Composite 4,714.39 -61.47 (-1.29%)

Currencies

EUR/USD 1.1256 0.0000 (0.00%)
USD/JPY 113.3150 +0.0950 (0.08%)
GBP/USD 1.4502 -0.0004 (-0.02%)
USD/CAD 1.3850 +0.0002 (0.02%)
USD/HKD 7.7814 -0.0096 (-0.12%)
USD/CNY 6.5326 0.0000 (0.00%)
AUD/USD 0.7117 +0.0011 (0.16%)

Bonds

3 Month 0.29% 0.00 (0.00%)
6 Month 0.37% -0.01 (-2.63%)
2 Year 0.70% +0.04 (6.06%)
5 Year 1.20% +0.04 (3.45%)
10 Year 1.75% +0.06 (3.55%)
30 Year 2.59% +0.07 (2.78%)
Bristol-Myers shares could rise 25 percent on cancer drug: Barron's
NEW YORK Shares of Bristol-Myers Squibb could rise 25 percent within a year because of its cancer-fighting drug Opdivo, which some analysts see generating $8 billion to $9 billion in annual sales in five years, Barron's said in its latest edition.
Bristol-Myers' Cancer Drug Could Push the Stock 25% Higher  
3 Reasons Bristol-Myers Squibb Co Stock Could Rise  
Market Chart
15,973.84 +313.66 (2.00%)
1,864.78 +35.70 (1.95%)
4,337.51 +70.68 (1.66%)

Top stories

China's central bank faces a difficult choice. Raising the yuan fixing on Monday to match last week's dollar drop would undo much of the benefits of January's depreciation.
0214_india_modi India's Prime Minister Narendra Modi speaks during the inauguration ceremony of the 'Make In India' week in Mumbai, India, February 13.
WASHINGTON - U.S. retail sales rose modestly in January, evidence that Americans kept shopping despite sharp drops in stock prices.
... * Equities index soars 18.3 percent in past four weeks. * Auto sector leads, pharma and engineering also strong. * Risks include banking debt, delay to economic reforms.
This is my least-favorite time of the year. Not only is it still cold up north, I have to spend hours preparing my taxes. And this is before my tax guy can even start his job!

Trends

Popular searches on GoogleChange Mkt Cap
FRO Frontline Ltd. 4.25% 11.53B

Sector summary

Sector Change % down / up
Energy +3.51%
Basic Materials +3.66%
Industrials +1.98%
Cyclical Cons. Goods ... +1.96%
Non-Cyclical Cons. Goods... +1.31%
Financials +3.43%
Healthcare +1.33%
Technology +1.17%
Telecommunications Servi... +1.26%
Utilities +0.26%